sulfinpyrazone has been researched along with Complication, Postoperative in 23 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Excerpt | Relevance | Reference |
---|---|---|
"Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis." | 6.15 | Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986) |
"Treatment with sulfinpyrazone (800 mg/day) was started 24 hours after operation in 130 patients; 125 patients received placebo." | 2.65 | Effects of sulfinpyrazone on early graft closure after myocardial revascularization. ( Baur, HR; Gobel, FL; Pierach, CA; VanTassel, RA, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sherry, S | 2 |
Sautter, RD | 2 |
Koch, EL | 1 |
Myers, WO | 1 |
Ray, JR | 1 |
Mazza, JJ | 1 |
Larson, DE | 1 |
Chen, HM | 1 |
Milbauer, JP | 1 |
Treuhaft, PS | 1 |
Plotka, ED | 1 |
Ordinas, A | 1 |
Barnett, HJ | 1 |
Gent, M | 3 |
Sackett, DL | 1 |
Taylor, DW | 1 |
Verstraete, M | 2 |
Baur, HR | 1 |
VanTassel, RA | 1 |
Pierach, CA | 1 |
Gobel, FL | 1 |
Loo, J | 1 |
Weiss, M | 1 |
Weiss, HJ | 1 |
Rogers, PH | 1 |
Walsh, PN | 1 |
Marder, VJ | 1 |
Bosak, GC | 1 |
Lachman, JW | 1 |
Ritchie, WG | 1 |
Oppenheimer, L | 1 |
Hirsh, J | 3 |
Dettori, AG | 1 |
Pini, M | 1 |
Quintavalla, R | 1 |
Gantmacher, ML | 1 |
Matt, EM | 1 |
Gruber, UF | 2 |
Buser, P | 1 |
Frick, J | 1 |
Loosli, J | 1 |
Matt, E | 1 |
Segesser, D | 1 |
Genton, E | 3 |
Harker, LA | 2 |
Maekawa, T | 1 |
Veth, G | 1 |
Meuwissen, OJ | 1 |
van Houwelingen, HC | 1 |
Sixma, JJ | 1 |
Weily, HS | 1 |
Steele, PP | 1 |
Davies, H | 1 |
Pappas, G | 1 |
9 reviews available for sulfinpyrazone and Complication, Postoperative
Article | Year |
---|---|
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; D | 1984 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof | 1980 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Hea | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
[Antiplatelet therapy of thrombosis].
Topics: Animals; Aspirin; Cerebrovascular Disorders; Coronary Disease; Humans; Postoperative Complications; | 1986 |
12 trials available for sulfinpyrazone and Complication, Postoperative
Article | Year |
---|---|
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fema | 1983 |
Randomized trial of therapy with platelet antiaggregants for threatened stroke. 2: Observations on the pathogenesis and natural history of threatened stroke.
Topics: Adolescent; Adult; Aged; Carotid Artery Thrombosis; Carotid Artery, Internal; Cerebrovascular Disord | 1980 |
Effects of sulfinpyrazone on early graft closure after myocardial revascularization.
Topics: Constriction, Pathologic; Coronary Circulation; Coronary Vessels; Female; Humans; Male; Middle Aged; | 1982 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Rela | 1975 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T | 1978 |
Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heparin; Hi | 1978 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin | 1975 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone.
Topics: Adult; Dihydroergotamine; Drug Therapy, Combination; Female; Heparin; Humans; Male; Middle Aged; Pos | 1985 |
5 other studies available for sulfinpyrazone and Complication, Postoperative
Article | Year |
---|---|
Potentiation of coumarin effect by sulfinpyrazone.
Topics: Coumarins; Drug Synergism; Drug Therapy, Combination; Embolism; Humans; Middle Aged; Postoperative C | 1979 |
[Prevention of postoperative thromboembolic complications with subcutaneously administered small doses of heparin].
Topics: Heparin; Humans; Injections, Subcutaneous; Postoperative Complications; Sulfinpyrazone; Thromboembol | 1977 |
Sulfinpyrazone and postoperative deep vein thrombosis.
Topics: Administration, Oral; Adult; Dextrans; Drug Evaluation; Fibrinogen; Heparin; Humans; Injections, Int | 1977 |
Etiology and prevention of thromboembolic disease. Taming a complex circulatory malfunction.
Topics: Antithrombin III Deficiency; Aspirin; Blood Coagulation Disorders; Catheters, Indwelling; Contracept | 1986 |
Platelet survival in patients with substitute heart valves.
Topics: Adenosine Diphosphate; Aortic Valve; Blood Platelets; Cell Survival; Chromium Radioisotopes; Collage | 1974 |